Tedizolid vs Linezolid for the Treatment of Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients

BACKGROUND: Treatment options for nontuberculous mycobacteria (NTM) infections are limited by the pathogen’s intrinsic resistance profile and toxicities. Tedizolid and linezolid display in vitro activity against NTM species. However, safety data and treatment outcomes are limited in the solid organ...

Descripción completa

Detalles Bibliográficos
Autores principales: Poon, Yi Kee, La Hoz, Ricardo M, Hynan, Linda S, Sanders, James, Monogue, Marguerite L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Novel ID Cases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047851/
https://www.ncbi.nlm.nih.gov/pubmed/33884276
http://dx.doi.org/10.1093/ofid/ofab093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047851/
https://www.ncbi.nlm.nih.gov/pubmed/33884276
http://dx.doi.org/10.1093/ofid/ofab093

Ejemplares similares